Newer oral antimicrobials for resistant respiratory tract pathogens
- 30 June 1998
- journal article
- review article
- Published by Taylor & Francis in Postgraduate Medicine
- Vol. 103 (6) , 67-76
- https://doi.org/10.3810/pgm.1998.06.514
Abstract
As antimicrobial resistance to tried-and-true drugs continues to build, an arsenal of new drugs aimed at resistant respiratory tract pathogens is needed. Penicillin is now ineffective against several common pathogens, including many pneumococcal organisms. Newer antimicrobials, including macrolides, cephalosporins, and fluoroquinolones, have been developed to take its place. The authors of this article present a progress report of the fight against respiratory tract infection and an assessment of the most promising newer agents for use against multidrug-resistant pathogens.Keywords
This publication has 16 references indexed in Scilit:
- Surveillance of antimicrobial resistance in Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis in the United States in 1996–1997 respiratory seasonDiagnostic Microbiology and Infectious Disease, 1997
- Dosing of Amoxicillin/Clavulanate Given Every 12 Hours Is as Effective as Dosing Every 8 Hours for Treatment of Lower Respiratory Tract InfectionClinical Infectious Diseases, 1997
- Comparison of Cefprozil, Cefpodoxime Proxetil, Loracarbef, Cefixime, and CeftibutenAnnals of Pharmacotherapy, 1996
- Trends in antimicrobial susceptibility of bacterial pathogens of the respiratory tractThe American Journal of Medicine, 1995
- Activities of oral and parenteral agents against penicillin-susceptible and -resistant pneumococciAntimicrobial Agents and Chemotherapy, 1995
- In vitro activities of 12 orally administered antimicrobial agents against four species of bacterial respiratory pathogens from U.S. Medical Centers in 1992 and 1993Antimicrobial Agents and Chemotherapy, 1994
- Management of Infections Caused by Antibiotic-Resistant Streptococcus PneumoniaeNew England Journal of Medicine, 1994
- The antibacterial activity of co-amoxiclavJournal of Antimicrobial Chemotherapy, 1993
- New Mechanisms of Bacterial Resistance to Antimicrobial AgentsNew England Journal of Medicine, 1991
- Therapeutic failure and selection of resistance to quinolones in a case of pneumococcal pneumonia treated with ciprofloxacinEuropean Journal of Clinical Microbiology & Infectious Diseases, 1990